Kayne Anderson Rudnick Investment Management’s Maravai LifeSciences MRVI Stock Holding History

Kayne Anderson Rudnick Investment Management’s Portfolio MRVI Stock Details MRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-201	Closed	-$2.01K	–	978
2023 Q3	$2.01K	Hold	201	–	–	﹤0.01%	688
2023 Q2	$2.5K	Hold	201	–	–	﹤0.01%	665
2023 Q1	$2.82K	Hold	201	–	–	﹤0.01%	616
2022 Q4	$2.88K	Hold	201	–	–	﹤0.01%	632
2022 Q3	$5K	Hold	201	–	–	﹤0.01%	583
2022 Q2	$6K	Hold	201	–	–	﹤0.01%	554
2022 Q1	$7K	Hold	201	–	–	﹤0.01%	545
2021 Q4	$8K	Hold	201	–	–	﹤0.01%	546
2021 Q3	$10K	Buy	201 +101	+101%	+$4.93K	﹤0.01%	518
2021 Q2	$4K	Hold	100	–	–	﹤0.01%	530
2021 Q1	$4K	Hold	100	–	–	﹤0.01%	524
2020 Q4	$3K	Buy	+100	New	+$2.79K	﹤0.01%	523

Other funds holding MRVI

GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return

1WCM

12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management's MRVI Position: Q4 2023 in Review

Kayne Anderson Rudnick Investment Management sold out of Maravai LifeSciences (MRVI) in Q4 2023, closing a stake of 201 shares — an estimated $2.01K sold.

Kayne Anderson Rudnick Investment Management first reported a position in MRVI in Q4 2020 and held it in 12 quarters. The position peaked at $10K in Q3 2021. 223 funds tracked by Wall St. Rank hold MRVI as of Q4 2023.

Kayne Anderson Rudnick Investment Management reported no remaining Maravai LifeSciences position as of Q4 2023 after selling out during the quarter.
Kayne Anderson Rudnick Investment Management sold 201 Maravai LifeSciences shares in Q4 2023, an estimated $2.01K.
Kayne Anderson Rudnick Investment Management first reported a position in Maravai LifeSciences in Q4 2020 and held it in 12 quarters.
Kayne Anderson Rudnick Investment Management's Maravai LifeSciences position peaked at $10K in Q3 2021.
223 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q4 2023.

Based on Kayne Anderson Rudnick Investment Management's 13F filing for Q4 2023, filed 13 Feb 2024.